Загрузка...
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Immune checkpoint blockade (ICB) results in durable disease control in a subset of patients with advanced renal cell carcinoma (RCC), but mechanisms driving resistance are poorly understood. We characterize the single-cell transcriptomes of cancer and immune cells from metastatic RCC patients before...
Сохранить в:
| Опубликовано в: : | Cancer Cell |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cell Press
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8115394/ https://ncbi.nlm.nih.gov/pubmed/33711272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2021.02.015 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|